ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,716Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 1006

$679K Total Retail Price of All Prescriptions

Rank: 110 out of 1006

345 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 345 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 345 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 8,236 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 429 365 1 8
FUROSEMIDE 378 318 2 6
AMLODIPINE BESYLATE 337 295 3 4
LISINOPRIL 316 243 4 3
ATORVASTATIN CALCIUM 294 279 5 5
LEVOTHYROXINE SODIUM 245 142 6 2
SIMVASTATIN 245 194 6 1
METOPROLOL TARTRATE 240 186 8 7
OMEPRAZOLE 229 177 9 9
TRAZODONE HCL 226 152 10 21
MIRTAZAPINE 153 130 11 26
TAMSULOSIN HCL 153 114 11 23
LANTUS 153 112 11 43
PANTOPRAZOLE SODIUM 152 112 14 32
CITALOPRAM HBR 143 109 15 24
METOPROLOL SUCCINATE 139 104 16 12
HYDROCHLOROTHIAZIDE 139 115 16 11
GABAPENTIN 137 97 18 20
POTASSIUM CHLORIDE 136 100 19 30
SERTRALINE HCL 131 88 20 19
METFORMIN HCL 117 82 21 10
RISPERIDONE 111 87 22 40
DONEPEZIL HCL 100 100 23 17
QUETIAPINE FUMARATE 94 57 24 45
NAMENDA 91 81 25 34
ADVAIR DISKUS 90 68 26 37
TRAMADOL HCL 90 64 26 35
ATENOLOL 89 50 28 13
EXELON 87 87 29 99
RANITIDINE HCL 83 53 30 63
PRAVASTATIN SODIUM 81 58 31 15
DIVALPROEX SODIUM 78 60 32 53
GLYBURIDE 76 72 R 33 65
ALENDRONATE SODIUM 76 75 33 29
LIDODERM 75 75 35 66
ZOLPIDEM TARTRATE 75 70 35 14
LOSARTAN POTASSIUM 74 62 37 22
SPIRONOLACTONE 73 50 38 71
LABETALOL HCL 73 63 38 164
NEXIUM 73 52 38 28
DIOVAN 72 53 41 16
PREDNISONE 68 55 42 33
JANUVIA 68 68 42 49
ESCITALOPRAM OXALATE 68 65 42 27
OXYCODONE-ACETAMINOPHEN 67 42 S2 45 57
NOVOLOG 66 49 46 94
CRESTOR 65 57 47 18
CLOPIDOGREL 65 57 47 46
CARVEDILOL 64 49 49 36
CIPROFLOXACIN HCL 61 46 50 75
CYMBALTA 58 43 51 41
GEMFIBROZIL 57 29 52 159
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 46 53 38
PLAVIX 55 43 53 61
OXYCODONE HCL 52 30 S2 55 54
FINASTERIDE 52 52 55 76
METFORMIN HCL ER 50 37 57 56
AMOX TR-POTASSIUM CLAVULANATE 50 29 57 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.